{
    "organizations": [],
    "uuid": "0aaf5321a6c6dc9d479c0a7f1d53b80751f01f3a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-achaogen-announces-positive-top-li/brief-achaogen-announces-positive-top-line-results-from-first-clinical-trial-of-orally-administered-antibacterial-candidate-c-scape-idUSASB0BZFD",
    "ord_in_thread": 0,
    "title": "BRIEF-Achaogen Announces Positive Top-Line Results From First Clinical Trial Of Orally-Administered Antibacterial Candidate C-Scape",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 16 PM / in 6 minutes BRIEF-Achaogen Announces Positive Top-Line Results From First Clinical Trial Of Orally-Administered Antibacterial Candidate C-Scape Reuters Staff \nJan 2 (Reuters) - Achaogen Inc: \n* ACHAOGEN ANNOUNCES POSITIVE TOP-LINE RESULTS FROM FIRST CLINICAL TRIAL OF ORALLY-ADMINISTERED ANTIBACTERIAL CANDIDATE C-SCAPE \n* ACHAOGEN INC - C-SCAPE WAS WELL TOLERATED ACROSS ALL DOSES STUDIED IN PHASE 1 TRIAL \n* ACHAOGEN INC - CONTINUE TO PLAN FOR PHASE 3 IN 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-01-02T15:15:00.000+02:00",
    "crawled": "2018-01-02T15:28:08.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "announces",
        "positive",
        "result",
        "first",
        "clinical",
        "trial",
        "antibacterial",
        "candidate",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "achaogen",
        "inc",
        "achaogen",
        "announces",
        "positive",
        "result",
        "first",
        "clinical",
        "trial",
        "antibacterial",
        "candidate",
        "achaogen",
        "inc",
        "well",
        "tolerated",
        "across",
        "dos",
        "studied",
        "phase",
        "trial",
        "achaogen",
        "inc",
        "continue",
        "plan",
        "phase",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}